• #1199197
  • Merck #00006432903

Vaxneuvance™ Pneumonia Vaccine Indicated for People 6 Weeks of Age and Older Pneumococcal 15-valent Conjugate Vaccine [Diphtheria CRM197 Protein], Preservative Free 2 mcg - 4 mcg - 30 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL

VAXNEUVANCE, SYR 0.5ML (10/BX)

Features
  • VAXNEUVANCE™ is a vaccine indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older
  • Children: Administer VAXNEUVANCE as a 4-dose series at 2, 4, 6 and 12 through 15 months of age
  • Adults: Administer VAXNEUVANCE as a single dose in adults 18 years of age and older
  • More …
  Log In to Order
or

Product Specifications


Features
  • VAXNEUVANCE™ is a vaccine indicated for active immunization for the prevention of invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, 22F, 23F and 33F in individuals 6 weeks of age and older
  • Children: Administer VAXNEUVANCE as a 4-dose series at 2, 4, 6 and 12 through 15 months of age
  • Adults: Administer VAXNEUVANCE as a single dose in adults 18 years of age and older
  • 10 Per Package

Professionals Also Viewed